Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 42

1.

Vitamin D levels and their impact on mineral metabolism in HIV infected patients: an exploratory study.

Mastaglia S, Watson D, Bello N, Fridman V, Stecher D, Oliveri B.

Clin Cases Miner Bone Metab. 2017 Jan-Apr;14(1):18-22. doi: 10.11138/ccmbm/2017.14.1.018. Epub 2017 May 30.

2.

Changes in bone turnover markers with HIV seroconversion and ART initiation.

Slama L, Reddy S, Phair J, Palella FJ Jr, Brown TT; Multicenter AIDS Cohort Study group (MACS).

J Antimicrob Chemother. 2017 May 1;72(5):1456-1461. doi: 10.1093/jac/dkx011.

3.

Vitamin D Deficiency and Metabolism in HIV-Infected and HIV-Uninfected Men in the Multicenter AIDS Cohort Study.

Zhang L, Tin A, Brown TT, Margolick JB, Witt MD, Palella FJ Jr, Kingsley LA, Hoofnagle AN, Jacobson LP, Abraham AG.

AIDS Res Hum Retroviruses. 2017 Mar;33(3):261-270. doi: 10.1089/AID.2016.0144. Epub 2016 Nov 17.

4.

Validation Protocol of Vitamin D Supplementation in Patients with HIV-Infection.

Lerma-Chippirraz E, Güerri-Fernández R, Villar García J, González Mena A, Guelar Grinberg A, Montero MM, Sorli L, Calzado S, Horcajada JP, Díez-Pérez A, Knobel Freud H.

AIDS Res Treat. 2016;2016:5120831. Epub 2016 Sep 6.

5.

Contribution of Genetic Background and Clinical Risk Factors to Low-Trauma Fractures in Human Immunodeficiency Virus (HIV)-Positive Persons: The Swiss HIV Cohort Study.

Junier T, Rotger M, Biver E, Ledergerber B, Barceló C, Bartha I, Kovari H, Schmid P, Fux C, Bernasconi E, Brun Del Re C, Weber R, Fellay J, Tarr PE.

Open Forum Infect Dis. 2016 May 18;3(2):ofw101. doi: 10.1093/ofid/ofw101. eCollection 2016 Apr.

6.

Vitamin D and bone loss in HIV.

Hileman CO, Overton ET, McComsey GA.

Curr Opin HIV AIDS. 2016 May;11(3):277-84. doi: 10.1097/COH.0000000000000272. Review.

7.

Safety and Efficacy of High-Dose Daily Vitamin D3 Supplementation in Children and Young Adults Infected With Human Immunodeficiency Virus.

Dougherty KA, Schall JI, Zemel BS, Tuluc F, Hou X, Rutstein RM, Stallings VA.

J Pediatric Infect Dis Soc. 2014 Dec;3(4):294-303. doi: 10.1093/jpids/piu012. Epub 2014 Mar 27.

8.

Vitamin D3 supplementation in HIV infection: effectiveness and associations with antiretroviral therapy.

Coelho L, Cardoso SW, Luz PM, Hoffman RM, Mendonça L, Veloso VG, Currier JS, Grinsztejn B, Lake JE.

Nutr J. 2015 Aug 18;14:81. doi: 10.1186/s12937-015-0072-6.

9.

Vitamin D supplementation and antibacterial immune responses in adolescents and young adults with HIV/AIDS.

Chun RF, Liu NQ, Lee T, Schall JI, Denburg MR, Rutstein RM, Adams JS, Zemel BS, Stallings VA, Hewison M.

J Steroid Biochem Mol Biol. 2015 Apr;148:290-7. doi: 10.1016/j.jsbmb.2014.07.013. Epub 2014 Aug 1. Review.

10.

High-dose vitamin D3 supplementation in children and young adults with HIV: a randomized, placebo-controlled trial.

Stallings VA, Schall JI, Hediger ML, Zemel BS, Tuluc F, Dougherty KA, Samuel JL, Rutstein RM.

Pediatr Infect Dis J. 2015 Feb;34(2):e32-40. doi: 10.1097/INF.0000000000000483.

11.

Vitamin D deficiency and altered bone mineral metabolism in HIV-infected individuals.

Eckard AR, McComsey GA.

Curr HIV/AIDS Rep. 2014 Sep;11(3):263-70. doi: 10.1007/s11904-014-0218-8. Review.

12.

Determination of optimal vitamin D3 dosing regimens in HIV-infected paediatric patients using a population pharmacokinetic approach.

Foissac F, Meyzer C, Frange P, Chappuy H, Benaboud S, Bouazza N, Friedlander G, Souberbielle JC, Urien S, Blanche S, Tréluyer JM.

Br J Clin Pharmacol. 2014 Nov;78(5):1113-21. doi: 10.1111/bcp.12433.

13.

Vitamin D insufficiency and subclinical atherosclerosis in non-diabetic males living with HIV.

Portilla J, Moreno-Pérez O, Serna-Candel C, Escoín C, Alfayate R, Reus S, Merino E, Boix V, Giner L, Sánchez-Payá J, Picó A.

J Int AIDS Soc. 2014 May 13;17:18945. doi: 10.7448/IAS.17.1.18945. eCollection 2014.

14.

Change in vitamin d levels occurs early after antiretroviral therapy initiation and depends on treatment regimen in resource-limited settings.

Havers FP, Detrick B, Cardoso SW, Berendes S, Lama JR, Sugandhavesa P, Mwelase NH, Campbell TB, Gupta A; ACTG A5175 PEARLS and NWCS319 Study Teams.

PLoS One. 2014 Apr 21;9(4):e95164. doi: 10.1371/journal.pone.0095164. eCollection 2014.

15.

Vitamin D status of human immunodeficiency virus-positive patients with advanced liver disease enrolled in the solid organ transplantation in HIV: multi-site study.

Branch AD, Barin B, Rahman A, Stock P, Schiano TD.

Liver Transpl. 2014 Feb;20(2):156-64. doi: 10.1002/lt.23784. Epub 2013 Dec 12.

16.

Per oral substitution with 300000 IU vitamin D (Cholecalciferol) reduces bone turnover markers in HIV-infected patients.

Piso RJ, Rothen M, Rothen JP, Stahl M, Fux C.

BMC Infect Dis. 2013 Dec 6;13:577. doi: 10.1186/1471-2334-13-577.

17.

Prevalence and Factors Associated with Vitamin D Deficiency and Hyperparathyroidism in HIV-Infected Patients Treated in Barcelona.

Lerma E, Molas ME, Montero MM, Guelar A, González A, Villar J, Diez A, Knobel H.

ISRN AIDS. 2012 Jul 12;2012:485307. doi: 10.5402/2012/485307. eCollection 2012.

18.

Vitamin D-related host genetic variants alter HIV disease progression in children.

Moodley A, Qin M, Singh KK, Spector SA.

Pediatr Infect Dis J. 2013 Nov;32(11):1230-6. doi: 10.1097/INF.0b013e31829e4d06.

19.

Cross-sectional study of vitamin D levels, immunologic and virologic outcomes in HIV-infected adults.

Bearden A, Abad C, Gangnon R, Sosman JM, Binkley N, Safdar N.

J Clin Endocrinol Metab. 2013 Apr;98(4):1726-33. doi: 10.1210/jc.2012-4031. Epub 2013 Mar 1.

20.

Vitamin D attenuates nucleoside reverse transcriptase inhibitor induced human skeletal muscle mitochondria DNA depletion.

Campbell GR, Pallack ZT, Spector SA.

AIDS. 2013 Jun 1;27(9):1397-401. doi: 10.1097/QAD.0b013e32836010dd.

Supplemental Content

Support Center